BCU-FTS-57591 Blood Transfusion Managed Service

Procurement reference

BCU-FTS-57591

Procurement description

Betsi Cadwaladr University Health Board (BCUHB) Pathology are seeking to appoint an experienced primary Managed Service Contract provider to deliver bespoke In Vitro Diagnostics support for Transfusion services.

BCUHB delivers Transfusion services for Group and Antibody screens, Cross matching, and issuing of products (via remote and electronic

issue) across all 3 acute sites (Ysbyty Wrexham Maelor, Ysbyty Glan Clwyd and Ysbyty Gwynedd), with blood stocks provided on a

remote/electronic issue basis to satellite services in Abergele, Denbigh, and Llandudno hospitals. The service is registered as compliant

with MHRA, and shares a single unified UKAS accreditation across all 3 locations. Each acute site has a fully capable Transfusion

laboratory area as part of the Blood Science laboratory and operates on a 24/7 basis as an established and resilient service model. Each site

also supports theatres, cancer centres and renal units with the relevant specialist requirements.

Main category

Services

Delivery regions

• UKL23 - Flintshire and Wrexham
• UKL13 - Conwy and Denbighshire
• UKL12 - Gwynedd

Contract dates (estimated)

01 April 2028, 00:00AM to 31 March 2036, 23:59PM

Extension end date (if all the extensions are used): 31 March 2043

Betsi Cadwaladr University Health Board

Is the total value above threshold?

Above threshold

CPV classifications

• 85111800 - Pathology services
• 85111810 - Blood analysis services
• 71900000 - Laboratory services

Delivery regions

• UKL23 - Flintshire and Wrexham
• UKL13 - Conwy and Denbighshire
• UKL12 - Gwynedd

Contract start date (estimated)

01 April 2028, 00:00AM

Contract end date (estimated)

31 March 2036, 23:59PM

Extension end date (estimated)

31 March 2043, 23:59PM

Can the contract be extended?

Yes

Publication date of tender notice (estimated)

01 April 2026